ASWC.DE vs. GSK.L

Last updated Jun 5, 2026

ASWC.DE (HANetf Future of Defence UCITS ETF Acc EUR) is Aerospace & Defense fund tracking the EQM Future of Defence Index, while GSK.L (GlaxoSmithKline plc) is a stock. Over the past year, ASWC.DE returned 16.04% vs 29.56% for GSK.L. At a 0.05 correlation, their price movements are largely independent.

Performance

ASWC.DE vs. GSK.L - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in HANetf Future of Defence UCITS ETF Acc EUR (ASWC.DE) and GlaxoSmithKline plc (GSK.L). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

ASWC.DE is traded in EUR, while GSK.L is traded in GBp. To make them comparable, the GSK.L values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, ASWC.DE achieves a 13.04% return, which is significantly higher than GSK.L's 9.13% return.

ASWC.DE

• 1D: -0.80%
• 1M: 8.64%
• YTD: 13.04%
• 6M: 15.13%
• 1Y: 16.04%
• 3Y*: —
• 5Y*: —
• 10Y*: —

GSK.L

• 1D: 0.00%
• 1M: 6.18%
• YTD: 9.13%
• 6M: 9.45%
• 1Y: 29.56%
• 3Y*: 16.14%
• 5Y*: 6.42%
• 10Y*: 4.68%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ASWC.DE vs. GSK.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
ASWC.DE HANetf Future of Defence UCITS ETF Acc EUR	13.04%	38.30%	39.36%	14.35%
GSK.L GlaxoSmithKline plc	9.13%	34.08%	1.15%	5.90%

Correlation

The correlation between ASWC.DE and GSK.L is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.05
Correlation (All Time) Calculated using the full available price history since Jul 5, 2023	0.05

The correlation between ASWC.DE and GSK.L shifts across timeframes, from -0.05 (1 year) to 0.05 (all time), reflecting how their relationship changes across market environments.

Return for Risk

ASWC.DE vs. GSK.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASWC.DE

ASWC.DE Risk / Return Rank: 25
ASWC.DE Sharpe Ratio Rank: 25
ASWC.DE Sortino Ratio Rank: 25
ASWC.DE Omega Ratio Rank: 24
ASWC.DE Calmar Ratio Rank: 29
ASWC.DE Martin Ratio Rank: 24

GSK.L

GSK.L Risk / Return Rank: 74
GSK.L Sharpe Ratio Rank: 78
GSK.L Sortino Ratio Rank: 76
GSK.L Omega Ratio Rank: 73
GSK.L Calmar Ratio Rank: 72
GSK.L Martin Ratio Rank: 73

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASWC.DE vs. GSK.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for HANetf Future of Defence UCITS ETF Acc EUR (ASWC.DE) and GlaxoSmithKline plc (GSK.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ASWC.DE	GSK.L	Difference
Sharpe ratio: Return per unit of total volatility	0.84	1.17	-0.33
Sortino ratio: Return per unit of downside risk	1.30	1.83	-0.53
Omega ratio: Gain probability vs. loss probability	1.16	1.22	-0.07
Calmar ratio: Return relative to maximum drawdown	1.36	1.69	-0.33
Martin ratio: Return relative to average drawdown	3.10	3.83	-0.73
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ASWC.DE vs. GSK.L - Sharpe Ratio Comparison

The current ASWC.DE Sharpe Ratio is 0.84, which is comparable to the GSK.L Sharpe Ratio of 1.17. The chart below compares the historical Sharpe Ratios of ASWC.DE and GSK.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ASWC.DE	GSK.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.84	1.17	-0.33
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.27	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.21	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.91	0.20	+1.71

Drawdowns

ASWC.DE vs. GSK.L - Drawdown Comparison

The maximum ASWC.DE drawdown since its inception was -12.58%, smaller than the maximum GSK.L drawdown of -44.69%. Use the drawdown chart below to compare losses from any high point for ASWC.DE and GSK.L.

Drawdown Indicators

	ASWC.DE	GSK.L	Difference
Max Drawdown Largest peak-to-trough decline	-12.58%	-44.69%	+32.11%
Max Drawdown (1Y) Largest decline over 1 year	-12.58%	-17.46%	+4.88%
Max Drawdown (3Y) Largest decline over 3 years	—	-27.45%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-44.69%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-44.69%	—
Current Drawdown Current decline from peak	-2.83%	-12.18%	+9.35%
Average Drawdown Average peak-to-trough decline	-2.47%	-15.65%	+13.18%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.51%	7.70%	-2.19%

Volatility

ASWC.DE vs. GSK.L - Volatility Comparison

HANetf Future of Defence UCITS ETF Acc EUR (ASWC.DE) and GlaxoSmithKline plc (GSK.L) have volatilities of 5.89% and 6.01%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ASWC.DE	GSK.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.89%	6.01%	-0.12%
Volatility (6M) Calculated over the trailing 6-month period	15.89%	17.81%	-1.92%
Volatility (1Y) Calculated over the trailing 1-year period	20.35%	25.30%	-4.95%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.12%	24.19%	-5.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.12%	22.58%	-3.46%

Dividends

ASWC.DE vs. GSK.L - Dividend Comparison

ASWC.DE has not paid dividends to shareholders, while GSK.L's dividend yield for the trailing twelve months is around 3.50%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ASWC.DE HANetf Future of Defence UCITS ETF Acc EUR	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
GSK.L GlaxoSmithKline plc	3.50%	3.51%	4.53%	3.84%	5.30%	4.93%	5.90%	4.45%	5.31%	5.99%	4.88%	5.77%

Frequently Asked Questions

Can I hold both ASWC.DE and GSK.L in my portfolio?

ASWC.DE and GSK.L have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.